{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Return to msk.org
Memorial Sloan Kettering Cancer Center
  • Sign In
  • Live Courses
  • On Demand eLearning
  • Coming Soon
  • Visiting Us
  • About
  • Resources & Policies
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Select a button below to sign in or create an account. If you have previously registered or attended a MSK CME event, please sign in using the username and password created at course registration. MSK employees must use their SSO credentials to sign in. 

Single Sign On (MSK Employees)
Sign in or Create an Account
Enter your email and password to login:

*
*
Login

New to Memorial Sloan Kettering Cancer Center? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ACHPN
  • ACNP
  • ACNP-BC
  • AGACNP
  • AGACNP-BC
  • AGCNS
  • AGNP
  • AGNP-BC
  • ANP
  • ANP-BC
  • AS
  • AT
  • AuD
  • BA
  • BAO
  • BCC
  • BCh
  • Bchir
  • BM
  • BS
  • BS, MS
  • BSN
  • BSN, MS
  • BSN, MS, DNP
  • CCC-SLP
  • CCLS
  • CCRN
  • CCRP
  • CEN
  • ChB
  • CIPS
  • CNM
  • CNP
  • CPNP
  • CPNP-AC
  • CRNA
  • CRNP
  • CTTS
  • D(ABMM)
  • DAc
  • DACM
  • DAHM
  • DAOM
  • DDS
  • DDS, MPH
  • DMD
  • DMD, PhD
  • DNB
  • DNP
  • DNP, RN
  • DNSc
  • DO
  • DPM
  • DPM
  • DPT
  • DrPH
  • DSc
  • DVM
  • EdD
  • EdS
  • FAAP
  • FACNM
  • FACOG
  • FACS
  • FASCRS
  • FASN
  • FCCM
  • FCCP
  • FIPP
  • FNP
  • FNP-BC
  • GNP
  • GNP-BC
  • HUC
  • JD
  • LAc
  • LCSW
  • LISW
  • LISW-S
  • LMSW
  • LPCC
  • LPN
  • LSW
  • MA
  • MAc
  • MAcOM
  • MB
  • MB, PhD
  • MBA
  • MBBCh
  • MBBCh BAO
  • MBBCh BAO, PhD
  • MBBCh, MPH
  • MBBCh, PhD
  • MBBS
  • MBBS, MPH
  • MBBS, PhD
  • MBChB
  • MD
  • MD, DSc
  • MD, FCCP
  • MD, FCCP, DAABIP
  • MD, JD
  • MD, MA
  • MD, MAS
  • MD, MBA
  • MD, MHA
  • MD, MPH
  • MD, MPH, MHS
  • MD, MS
  • MD, MS, PhD
  • MD, PhD
  • MD, PhD, MA
  • MD, PhD, MPH
  • MD, PhD, MS
  • MDiv
  • MDS
  • MEd
  • MHS
  • MPA
  • MPH
  • MPhil
  • MS
  • MSc
  • MSc, PhD
  • MSN
  • MSPH
  • NCTTP
  • None
  • NP
  • NP, RN
  • OCN
  • OD
  • Other
  • OTR
  • PA
  • PA-C
  • PCA
  • PharmD
  • PharmD, PhD
  • PhD
  • PhD, MBA, MS
  • PhD, MPH
  • PhD, MPhil
  • PhD, MS
  • PhD, MSc
  • PhD, NP, RN
  • PsyD
  • PT
  • RA
  • RCS
  • RD
  • RDCS
  • RDMS
  • RN
  • RN-BC
  • RPh
  • RRT
  • RT
  • ScD
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

8th Annual MSK Symposium on Lymphoma


8th Annual MSK Symposium on Lymphoma Banner

  • Overview
  • Register
  • Brochure
  • Faculty
  • Schedule
  • Accommodations
  • Sponsors
  • Support
Add to Calendar 8th Annual MSK Symposium on Lymphoma 4/26/2024 8:00:00 AM 4/27/2024 2:00:00 PM America/New_York For More Details: https://mskcc.cloud-cme.com/course/courseoverview?EID=47534 Description: Join us for the 8th edition of the MSK Symposium on Lymphoma, where renowned international and national experts will provide a comprehensive update on the continually evolving landscape of lymphoma research. Explore the latest breakthroughs in lymphoma biology, cutting-edge diagnostics, and groundbreaking treatment strategies that are reshaping the future of patient care. This year’s symposium will f... Zuckerman Research Center, 417 East 68th Street false MM/DD/YYYY


Date & Location
Friday, April 26, 2024, 8:00 AM - Saturday, April 27, 2024, 2:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

Specialties
Specialties - Anatomic Pathology, Bone Marrow Transplant, Clinical Pathology, Geriatric Medicine, Hematology, Immunotherapy, Internal Medicine, Laboratory Medicine, Leukemia, Lymphoma, Medical Oncology, Nuclear Medicine, Oncology and Hematology, Radiation Oncology

Overview

Join us for the 8th edition of the MSK Symposium on Lymphoma, where renowned international and national experts will provide a comprehensive update on the continually evolving landscape of lymphoma research. Explore the latest breakthroughs in lymphoma biology, cutting-edge diagnostics, and groundbreaking treatment strategies that are reshaping the future of patient care.

This year’s symposium will focus on the clinical management of the most prevalent lymphoma types, while also unveiling exciting developments in new drugs that promise to revolutionize treatment options. Faculty will present these innovations and engage in dynamic panel discussions on how to practically tailor patient care for the best outcomes. Furthermore, the program will include an impactful keynote lecture, exciting hot topics, and extensive networking opportunities, both during breaks and at the networking reception and concluding luncheon. Specifically for our interprofessional care team, a dedicated session on nursing professional development will be offered.

Don't miss the opportunity to explore the latest advancements in lymphoma biology and pathology, understanding how these discoveries pave the way for innovative therapies. Join us in the exploration from scientific breakthroughs to solutions, alongside our distinguished faculty.

This symposium offers participants the choice of attending either in person at Memorial Sloan Kettering's Zuckerman Research Center or virtually via Zoom. Exclusive sessions are available to those who attend in person.


EXCLUSIVE IN-PERSON SESSIONS

In-person attendees have the chance to register for exclusive sessions available only to those attending in person, including:

Nursing Professional Development Breakout Session — Friday, April 26

We're excited to offer a dedicated session to the education of nursing professionals on Friday. As this session is limited to 35 participants, we encourage early registration.

Welcome Networking Reception — Friday, April 26

We invite attendees to join the symposium faculty for a networking reception on of Friday evening. This exclusive event will take place in the lobby of the Zuckerman Research Center, and RSVP is required for attendance. To confirm your participation in the reception, please select this option during your registration. Hors d'oeuvres and refreshments will be served.

Concluding Luncheon — Saturday, April 27

We invite attendees to join us for a farewell luncheon on Saturday afternoon following the symposium's conclusion. To confirm your participation in the luncheon, please select this option during your registration.


Online Syllabus

Attendees will receive access to an online syllabus after the symposium. This will include select PDFs of the faculty presentations (slides) and recorded videos from the symposium. Please note that the Nursing Professional Development Breakout Session will be recorded and made available on the syllabus to all attendees.

Who Should Attend

The target audience for this symposium includes internists, oncologists, hematologists as well as medical and radiation oncologists, hematopathologists, scientists, and medical trainees involved in the diagnosis, treatment, and biomedical research of lymphoma.

Objectives
At the conclusion of this symposium, attendees will be able to:

  1. Describe recent refinements in lymphoma classification
  2. Discuss first line treatment options in the most frequent lymphoma entities
  3. Discuss options and recommendations for patients in the relapse refractory setting, including the integration of recently approved therapies
  4. Provide adequate information to help shared decision making with patients regarding their treatment

Registration

This symposium offers participants the choice of attending either in person or virtually. In-person registration includes continental breakfast, lunch, refreshment breaks, and a complimentary invitation to both the networking reception. as well as the luncheon reception. Please contact [email protected] at least one week prior to the symposium if you have any special dietary requests or require any specific accommodations.

Registration Fees

  • Physicians (MDs, PhDs, and DOs): $450
  • Advanced Practice Providers: $200
  • Nurses and Other Healthcare Providers: $150
  • Residents, and Fellows: $100
  • Employees of Pharma and Medical Devices: $785*
  • MSK Employees: Complimentary

*Employees who are currently employed by a Pharmaceutical and Medical Device company may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

MSK Alumni and MSK Cancer Alliance Member Discount: A discounted registration rate is offered to MSK Alumni and MSK Cancer Alliance members for all CME programs at MSK. If you belong to either of these groups, please submit your request here to receive a promotion code to be applied at registration.

MSK Employees: MSK employees can register for any CME program on a complimentary basis. Employees need to log in to the MSK CME Portal using their SS0 login credentials and register for the desired program. We kindly request that those who register also plan to attend. If you are registered for this program and unable to attend, please notify us by emailing [email protected].

Please note that after your payment has been processed, no further promotional discount adjustments will be made to your registration.

Cancellation Policy

If you wish to cancel your participation in this symposium, you must email [email protected] at least seven (7) days prior to the start of the symposium, and your refund will be subject to a $25 administrative fee if attending virtually or a $100 administrative fee if attending in-person. Cancellations or no-shows within seven (7) days of the symposium are not eligible for a refund. Please note that if it has been more than 120 days since payment was processed, a W9 form must be submitted in order process your refund and your refund will be issued in the form of a check payment. Refunds are not subject to tax. You may substitute another registrant in your place at any time by contacting [email protected] with the appropriate information.

MSK CME reserves the right to cancel or postpone any symposium due to unforeseen circumstances. In the unlikely event we must cancel or postpone this symposium, you will be notified via email from MSK CME ([email protected]). A full refund will be issued for your registration. MSK CME is not responsible for any related costs, charges, or expenses to participants, including fees incurred by airline/travel/lodging agencies.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this live activity for a maximum of 12.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statements

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 12.75 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program; and
  • 12.75 Lifelong Learning (CME) credits in the American Board of Pathology’s (ABPath) Continuing Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABPath MOC/CC credit.

ANCC CNE Statement

Memorial Sloan Kettering Cancer Center–Nursing Professional Development / Continuing Education is accredited with distinction as a provider of nursing continuing professional development (NCPD) by the American Nurses Credentialing Center’s Commission on Accreditation.

12.75 contact hours will be awarded to participants who attend the program in its entirety and complete a program evaluation. Partial credit not awarded.



Keywords: ABIM MOCAMA PRA Category 1Nursing Credit ABPath CC


Hotel Accommodations

We look forward to welcoming you to Memorial Sloan Kettering for this program. If you’ll be traveling to New York City from out of town, we recommend that you plan your overnight stays as soon as possible. To make the planning a little easier, Memorial Sloan Kettering has negotiated special rates and amenities at select hotels in Manhattan. To view the list of select hotels and additional details on each, please visit: msk.org/accommodations

Parking Information

Street parking in Manhattan is extremely limited, so you may find it more convenient to park in Memorial Sloan Kettering’s garage or in a commercial garage. For a list of parking resources around MSK, click here. Please note that MSK CME does not offer parking validation for course attendees.



MSK Symposium Director

Gilles Salles, MD, PhD
Chief, Lymphoma Service

 

MSK Planning Committee

Ahmet Dogan, MD, PhD
Chief, Hematopathology Service

Kojo S.J. Elenitoba-Johnson, MD
Chair, Department of Pathology and Laboratory Medicine 

Steven Horwitz, MD
Attending, Lymphoma Service

Andrew Intlekofer, MD
Assistant Attending, Lymphoma Service

Ariela Noy, MD
Attending, Lymphoma Service

Quinlan Sievers, MD, PhD
Hematology/Oncology Fellow

Hans-Guido Wendel, MD
Member/Professor, Cancer Biology and Genetics Program

Joachim Yahalom, MD, FACR, FASTRO
Attending, External Beam Radiotherapy Service

Andrew D. Zelenetz, MD, PhD 
Medical Director, Quality Informatics;
Attending, Lymphoma Service 

 

Invited Symposium Faculty 

Irene Buvat, PhD
Director, Laboratory of Translational Imaging in Oncology (LITO),
Curie Institute, Inserm, CNRS
Paris, France

Kate Cwynarski, MD, PhD
Haem-Oncologist/Lymphoma Lead;
Honorary Associate Professor,
University College London Hospital 
London, United Kingdom

Matthew Davids, MD, MMSc
Associate Professor of Medicine, 
Harvard Medical School;
Leader, Lymphoma Program,
Dana-Farber/Harvard Cancer Center;
Director of Clinical Research, Division of Lymphoma,
Dana-Farber Cancer Institute
Boston, MA

Carl DeSelm, MD, PhD
Assistant Professor, Radiation Oncology,
Washington University School of Medicine
St. Louis, MO

Philippe Gaulard, MD
Professor,
Henri-Mondor Hospital
Paris, France

Ann LaCasce, MD, MMSc
Associate Professor of Medicine;
Program Director, Dana-Farber/Mass General Brigham Fellowship in Hematology;
Dana-Farber Cancer Institute
Boston, MA

Teresa Palomero, PhD
Professor of Pathology and Cell Biology,
Institute for Cancer Genetics
New York, NY

Marco Ruella, MD
Assistant Professor of Medicine,
University of Pennsylvania
Philadelphia, NY

Shayna Sarosiek, MD
Assistant Professor of Medicine, 
Harvard Medical School;
Senior Physician,
Dana-Farber Cancer Institute
Boston, MA


Laurie Sehn, MD, MPH
Clinical Professor,
BC Cancer and The University of British Columbia
Vancouver, British Columbia, Canada

Sonali Smith, MD
Elwood V. Jensen Professor of Medicine;
Section Chief, Hematology/Oncology,
The University of Chicago
Chicago, IL

Christian Steidl, MD, PhD
Executive Director, Research,
BC Cancer Research Centre
Vancouver, British Columbia, Canada

Gita Thanarajasingam, MD
Associate Professor of Medicine;
Consultant, Lymphoma Disease Group,
Mayo Clinic
Rochester, MN

Julie Vose, MD, MBA
Neumann M. and Mildred E. Harris Professor; 
Chief, Division of Hematology/Oncology,
University of Nebraska Medical Center
Omaha, Nebraska

 

MSK Symposium Faculty

Ashley Ames, MSN, RN, FNP-BC
Nurse Practitioner 

Annalisa Benz, BSN, RN, OCN
Clinical Nurse

Kevin David, MD
Associate Attending, Lymphoma  Service

Megan Dunne, RN, MA, ANP-BC, AOCNP
Nurse Practitioner 

Zachary Epstein-Peterson, MD
Attending, Lymphoma  Service


Lorenzo Falchi, MD
Assistant Attending, Lymphoma  Service

Pallavi Kanwar Galera, MBBS
Assistant Attending, Hematopathology Service

Paola Ghione, MD
Assistant Attending, Lymphoma  Service

Christian Grommes, MD
Associate Attending, Brain Tumor and Early Drug Development Services

Ashwath Gurumurthi, MBBS
Hematology/Oncology Fellow

Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care; 
Attending Physician, Lymphoma Service

Helen Hancock, MSN, AGNP-BC
Clinical Trials Research Nurse Practitioner


Brandon Imber, MD, MA
Assistant Attending, External Beam Radiotherapy and Early Drug Development Services

Varun Iyengar, MD
Hematology/Oncology Fellow


Anita Kumar, MD
Associate Attending, Lymphoma  Service

Megan So-Young Lim, MD, PhD
Director, Lymphoma Translational Research Program at the Center for Hematologic Malignancies; 
Attending, Department of Pathology and Laboratory Medicine

Jennifer K. Lue, MD
Assistant Attending; Clinical Director, Lymphoma Service

Anastasia Martinova, BSN, RN
Clinical Trials Nurse


Brittany McClain, MSN
Clinical Nurse IV 

Alison J. Moskowitz, MD
Associate Attending, Lymphoma  Service


Colette N. Owens, MD
Assistant Attending, Lymphoma and Genitourinary Oncology Services

M. Lia Palomba, MD
Attending; Member, Lymphoma and Cellular Therapeutics Services

Heiko Schöder, MD, MBA
Chief, Molecular Imaging and Therapy Service

Michael Scordo, MD
Assistant Attending, Adult Bone Marrow Transplant and Cellular Therapy Services 

Emily Spevack, BSN, RN, OCN
Office Practice Nurse

Raphael Steiner, MD
Associate Attending, Lymphoma Service

Robert Stuver, MD
Assistant Attending, Lymphoma  Service

Meghan C. Thompson, MD
Assistant Attending, Leukemia Service

Pallawi Torka, MD
Assistant Attending, Lymphoma  Service

Santosha Vardhana, MD, PhD
Assistant Member, Human Oncology and Pathogenesis Program;
Assistant Attending, Lymphoma Service

Jenna Wenzel, NP-C
Nurse Practitioner

Julie Ziemann, MS, AGNP-C, AOCNP
Nurse Practitioner



Mitigation of Relevant Financial Relationships


Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.



Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Gilles Salles, MD, PhD
MSK
Activity Director, Faculty
Advisor-Abbvie|Review Panel Member-Beigene|Advisor-Bristol-Myers Squibb|Consulting Fee-Epizyme (Relationship has ended)|Advisor-Genentech, Inc.|Advisor-Genmab|Advisor-Incyte Corporation|Advisor-Janssen (Relationship has ended)|Honoraria-Gilead (Relationship has ended)|Consulting Fee-Loxo (Relationship has ended)|Consulting Fee-Milteniy (Relationship has ended)|Consulting Fee-Morphosys (Relationship has ended)|Consulting Fee-Novartis AG (Relationship has ended)|Consulting Fee-Molecular Partners AG (Relationship has ended)|Consulting Fee-IPSEN|Consulting Fee-Nordic Nanovector (Relationship has ended)|Honoraria-Merck and Company, Inc.
Andrew Intlekofer, MD
MSK
Conflict of Interest Peer Reviewer, Faculty, Planner
Nothing to disclose
Ashley Ames, FNP-BC, NP
MSK
Faculty
Nothing to disclose
Annalisa Benz, BSN, RN, OCN
MSK
Faculty
Nothing to disclose
Irene Buvat, PhD, Dr
Curie Institute, Inserm, CNRS
France
Faculty
Grant or research support-GE Healthcare Bio-Sciences|Grant or research support-Siemens Healthineers|Grant or research support-Dosisoft (Relationship has ended)|Grant or research support-Roche|Grant or research support-Institut Roche
Kate Cwynarski, MD, PhD
University College London Hospital
United Kingdom
Faculty
Consulting Fee- Abbvie, Roche, KITE|Speakers Bureau-Roche, KITE, Gilead, BMS
Kevin David, MD
MSK
Faculty
Nothing to disclose
Matthew S Davids, MD, MMSc
Dana-Farber Cancer Institute
Faculty
Grant or research support-Novartis AG|Paid consultant-Abbvie|Paid consultant-AstraZeneca|Paid consultant-Bristol-Myers Squibb|Paid consultant-Eli Lilly and Company|Paid consultant-Genentech, Inc.|Paid consultant-Merck and Company, Inc.|Paid consultant-Takeda Pharmaceuticals, Inc.
Carl DeSelm, MD, PhD
Washington University School of Medicine
Faculty
Nothing to disclose
Megan Dunne, MA, ANP-C, AOCNP
MSK
Faculty
Nothing to disclose
Zachary D Epstein-Peterson, MD
MSK
Faculty
Advisor-Genmab (Relationship has ended)
Faculty Photos
Lorenzo Falchi, MD
MSK
Faculty
Grant or research support-Genmab|Consulting Fee-Genmab|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Consulting Fee-Abbvie|Grant or research support-Abbvie|Advisor-ADC Therapeutics (Relationship has ended)|Advisor-Seagen (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Consulting Fee-Evolveimmune (Relationship has ended)|Advisor-Ipsen (Relationship has ended)|Grant or research support-Innate
Pallavi Kanwar Galera, MBBS
MSK
Faculty
Grant or research support-Paige.AI
Philippe Gaulard, MD
Henri Mondor University Hospital
France
Faculty
Advisor-Takeda Pharmaceuticals, Inc.|Grant or research support-Sanofi-Aventis|Grant or research support-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Grant or research support-Innate Pharma (Relationship has ended)|Other: Travel coast, accomodation and registration (ICML)-Roche
Paola Ghione, MD, MS
MSK
Faculty
Honoraria-Oncology Independent Education (Relationship has ended)|Consulting Fee-ADC therapeutics (Relationship has ended)
Christian Grommes, MD
MSK
Faculty
Consulting Fee-Roche (Relationship has ended)|Consulting Fee-BTG (Relationship has ended)|Consulting Fee-Ono
Ashwath Gurumurthi, MBBS
MSKCC
Faculty
Honoraria-Kite Pharma (Relationship has ended)
Paul A Hamlin, MD
MSK
Faculty
Grant or research support-Alexion|Consulting Fee-AstraZeneca (Relationship has ended)|Advisor-Calithera|Consulting Fee-Karyopharm (Relationship has ended)|Grant or research support-Janssen |Grant or research support-Molecular Templates
Helen j Hancock, NP, RN
Lymphoma
Faculty
Nothing to disclose
Brandon Imber, MD
MSK
Faculty
Honoraria-GT Medical Technologies|Grant or research support-Novartis AG|Grant or research support-Bayer Corporation|Grant or research support-AstraZeneca|Grant or research support-Kazia|Honoraria-Telix (Relationship has ended)
Varun Iyengar, MD
MSK
Faculty
Nothing to disclose
Anita Kumar, MD
MSK
Faculty
Advisor-AstraZeneca|Consulting Fee-Genentech, Inc.|Advisor-Kite Pharmaceuticals (Relationship has ended)|Advisor-Janssen (Relationship has ended)|Grant or research support-Seattle Genetics|Grant or research support-Adaptive Biotechnologies|Grant or research support-Loxo Biotechnologies |Grant or research support-Celgene|Grant or research support-Incyte Corporation
Ann S LaCasce, MD
Dana-Farber Cancer Institute
Faculty
Speakers Bureau-Research to Practice|Advisor-Kite Pharma (Relationship has ended)|Advisor-Seagen (Relationship has ended)
Megan Lim, MD, PhD, Pathologist
MSK
Faculty
Grant or research support-Thermo Fisher Inc
Jennifer K Lue, MD
MSK
Faculty
Honoraria-Sanofi-Aventis (Relationship has ended)|Consulting Fee-Epizyme (now Ipsen) (Relationship has ended)|Consulting Fee-TG Therapeutics (Relationship has ended)|Consulting Fee-Merck and Company, Inc.|Consulting Fee-ADC Therapeutics |Consulting Fee-Genmab
Anastasia Martinova, BSN
MSK
Faculty
Nothing to disclose
Alison Moskowitz, MD
MSK
Faculty
Grant or research support-Seagen|Grant or research support-Merck and Company, Inc.|Grant or research support-Bristol-Myers Squibb|Grant or research support-Incyte Corporation|Grant or research support-SecuraBio|Honoraria-Seagen|Honoraria-Takeda Pharmaceuticals, Inc.|Honoraria-Merck and Company, Inc.|Honoraria-Affimed|Grant or research support-AstraZeneca
Colette Owens, MD
MSK
Faculty
Nothing to disclose
Lia Palomba, MD
MSK
Faculty
Advisor-Synthekine (Relationship has ended)|Advisor-MustangBio (Relationship has ended)|Advisor-Novartis AG (Relationship has ended)|Advisor-BeiGene (Relationship has ended)
Teresa Palomero, PhD
Columbia University Irving Medical Center
Faculty
Nothing to disclose
Marco Ruella, MD, Assistant Professor Medicine
University of Pennsylvania
Faculty
Other: Inventor-Univ. of Pennsylvania, partly licensed to Novartis, Tmunity, and viTToria biotherapeutics|Grant or research support-AbClon|Grant or research support-Beckman-Coulter|Grant or research support-Oxford Nano-Imaging (ONI)|Grant or research support-Lumicks|Grant or research support-viTToria Biotherapeutics|Other: DSMB-PeproMene|Consulting Fee-Gerson Lehrman Group (GLG)|Consulting Fee-Guidepoint|Advisor-viTToria Biotherapeutics|Advisor-AbClon|Advisor-Bristol-Myers Squibb|Advisor-Sana Biotechnology|Advisor-GlaxoSmithKline|Advisor-Bayer Corporation|Other: Scientific Founder-viTToria Biotherapeutics
Shayna Sarosiek, MD
Dana-Farber Cancer Institute
Faculty
Consulting Fee-Beigene (Relationship has ended)|Grant or research support-ADC Therapeutics|Consulting Fee-Cellectar (Relationship has ended)
Heiko Schoder, MD
MSK
Faculty
Nothing to disclose
Michael Scordo, MD
MSK
Faculty
Consulting Fee-Omeros Corporation|Grant or research support-Omeros Corporation|Grant or research support-Amgen, Inc. (Relationship has ended)|Consulting Fee-Kite - A Gilead Company (Relationship has ended)|Grant or research support-Angiocrine Bioscience, Inc.|Consulting Fee-Angiocrine Bioscience, Inc. (Relationship has ended)
Laurie H. Sehn, MD, MPH
BC Cancer and The University of British Columbia
Canada
Faculty
Consulting Fee-Abbvie (Relationship has ended)|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Consulting Fee-Gilead (Relationship has ended)|Consulting Fee-AstraZeneca (Relationship has ended)|Consulting Fee-Incyte Corporation (Relationship has ended)|Consulting Fee-Johnson and Johnson (Relationship has ended)|Consulting Fee-Merck and Company, Inc. (Relationship has ended)|Grant or research support-Genentech, Inc.|Consulting Fee-Roche (Relationship has ended)|Consulting Fee-Beigene (Relationship has ended)|Consulting Fee-Seagen (Relationship has ended)
Sonali Smith, MD
The University of Chicago
Faculty
Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-Ono PHarmaceuticals (Relationship has ended)
Emily Spevack, BSN
MSK
Faculty
Nothing to disclose
Christian Steidl, MD, PHD
BC Cancer Research Centre
Canada
Faculty
Consulting Fee-Bayer Corporation|Honoraria-Eisai, Inc. (Relationship has ended)
Raphael E Steiner , MD
MSK
Faculty
Grant or research support-Merck and Company, Inc. (Relationship has ended)|Grant or research support-Bristol-Myers Squibb (Relationship has ended)|Grant or research support-GlaxoSmithKline (Relationship has ended)|Grant or research support-Rafael Pharmaceuticals (Relationship has ended)
Robert Stuver, MD
MSK
Faculty
Nothing to disclose
Gita Thanarajasingam, MD
Mayo Clinic
Faculty
Advisor-SeaGen (Relationship has ended)|Advisor-Novartis AG (Relationship has ended)
Meghan C Thompson, MD
MSK
Faculty
Paid consultant-Beigene (Relationship has ended)|Grant or research support-Nurix Therapeutics (Relationship has ended)|Paid consultant-Janssen|Paid consultant-Loxo Oncology at Lilly (Relationship has ended)|Other: Payment for travel and lodging-Dava Oncology (Relationship has ended)|Paid consultant-AstraZeneca (Relationship has ended)
Pallawi Torka, MD
MSK
Faculty
Consulting Fee-Genentech, Inc. (Relationship has ended)|Consulting Fee-Seagen (Relationship has ended)|Consulting Fee-TG therapeutics (Relationship has ended)|Consulting Fee-ADC therapeutics (Relationship has ended)|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-Eli Lilly and Company (Relationship has ended)
Santosha Vardhana, MD, PhD
MSK
Faculty
Advisor-Immunai|Consulting Fee-ADC Therapeutics (Relationship has ended)|Consulting Fee-Koch Disruptive Technologies (Relationship has ended)
Julie M Vose, MD, MBA, Chief, Hematology/Oncology
University of Nebraska Medical Center
Faculty
Consulting Fee-GenMab, Abbvie, AstraZeneca, MSD, Abbvie, Seagen, MEI Pharma, Foresight Diagnostics, ONO, Adaptive, Gamida Cell
Jenna Wenzel, AGNP, AOCNP
MSKCC
Faculty
Employment-Genmab
Brittany McClain, MSN
MSK
Faculty, Nurse Content Expert
Nothing to disclose
Yuliya Ziemann, AGNP
MUSC
Faculty, Nurse Content Expert
Nothing to disclose
Ahmet Dogan, MD, PhD
MSK
Faculty, Planner
Consulting Fee-EUSA Pharma (Relationship has ended)|Grant or research support-Roche|Grant or research support-Takeda Pharmaceuticals, Inc.
Kojo Elenitoba-Johnson, MD
MSK
Faculty, Planner
Nothing to disclose
Steven Horwitz, MD
MSK
Faculty, Planner
Grant or research support-Kyowa|Consulting Fee-Kyowa (Relationship has ended)|Consulting Fee-Affimed (Relationship has ended)|Consulting Fee-TUBULIS (Relationship has ended)|Consulting Fee-Takeda Pharmaceuticals, Inc.|Grant or research support-Secura|Consulting Fee-Secura|Consulting Fee-Ono|Grant or research support-Daiichi Sankyo|Consulting Fee-Daiichi Sankyo (Relationship has ended)|Grant or research support-Crispr|Grant or research support-C4|Consulting Fee-Yingli (Relationship has ended)|Consulting Fee-Abcuro (Relationship has ended)|Consulting Fee-Autolus (Relationship has ended)|Consulting Fee-Auxilius Pharma (Relationship has ended)|Consulting Fee-CTI Bio Pharma Group (Relationship has ended)|Consulting Fee-Dren Bio|Consulting Fee-Seagen|Grant or research support-Seagen|Grant or research support-Trillium (Relationship has ended)|Grant or research support-Affimed (Relationship has ended)|Grant or research support-Takeda Millenium (Relationship has ended)|Consulting Fee-March Biosciences|Consulting Fee-Corvus Pharmaceuticals
Ariela Noy, MD
MSK
Faculty, Planner
Consulting Fee-Epizyme|Consulting Fee-Janssen|Other: Research funding-Abbvie|Other: Research funding-Cornerstone Pharma|Advisor-Morphosys (Relationship has ended)|Advisor-AstraZeneca|Grant or research support-Gilead|Advisor-kite Pharma|Honoraria-EUSA (Relationship has ended)|Honoraria-Recordati|Advisor-tg therapeutics (Relationship has ended)|Advisor-ADC therapeutics (Relationship has ended)
Hans-Guido Wendel, MD
MSK
Faculty, Planner
Nothing to disclose
Joachim Yahalom, MD
MSK
Faculty, Planner
Nothing to disclose
Andrew D Zelenetz, MD, PhD
MSK
Faculty, Planner
Consulting Fee-Genentech, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Roche|Consulting Fee-Roche|Consulting Fee-MEI Pharma (Relationship has ended)|Grant or research support-MEI Pharma (Relationship has ended)|Advisor-Bristol-Myers Squib Aventis|Consulting Fee-Gilead|Consulting Fee-AstraZeneca|Grant or research support-Beigene|Consulting Fee-Beigene|Consulting Fee-Novartis AG|Consulting Fee-AMGEN (Relationship has ended)|Consulting Fee-Abbvie|Consulting Fee-MorphoSys|Other: DMC Member-Bristol Myers Squibb/Celgene/Juno
Quinlan Sievers, MD, PhD
MSK
Faculty, Resident/Fellow Planner
Nothing to disclose
Melinda Leash, MBA
MSKCC
Nurse Planner
Nothing to disclose

Friday, April 26, 2024
Relevant Financial Relationships
8:00AM - 8:05AM

View faculty disclosures here. 
DLBCL: Advances in 2024
8:05AM - 9:00AM
Laurie H. Sehn, MD, MPH
Bispecific in DLBCL: When and How
9:00AM - 9:25AM
Lorenzo Falchi, MD
Challenges in CAR T-cell Therapy
9:25AM - 9:50AM
Marco Ruella, MD, Assistant Professor Medicine
Optimizing Radiation in the Context of CAR T-cell Therapy
9:50AM - 10:15AM
Carl DeSelm, MD, PhD
DLBCL: Evolving Standards of Care and Navigating Complex Scenarios Panel Discussion
10:15AM - 10:40AM
Ashwath Gurumurthi, MBBS (Presenter)
Evaluating AEs and Treatment Tolerability in Clinical Trials
11:00AM - 11:30AM
Gita Thanarajasingam, MD
Advances in Radiomics
11:30AM - 12:00PM
Irene Buvat, PhD, Dr
Challenges in Older Patients
12:00PM - 12:30PM
Pallawi Torka, MD
Pathology of T-cell lymphoma _T-helper T-cell Lymphoma
1:30PM - 2:00PM
Philippe Gaulard, MD
Epigenetic Profiling of T-cell Lymphoma
2:15PM - 2:30PM
Kojo Elenitoba-Johnson, MD
Recent Advances in T-cell Lymphoma Therapy
2:30PM - 3:00PM
Julie M Vose, MD, MBA, Chief, Hematology/Oncology
Pathological Insights and Contemporary Therapeutic Breakthroughs: Keeping Pace with Recent Advances Panel Discussion
3:00PM - 3:15PM
Varun Iyengar, MD (Presenter)
Recent Insights in iNHL Classifications
3:35PM - 3:50PM
Megan Lim, MD, PhD, Pathologist
Waldenström Macroglobulinemia
3:50PM - 4:10PM
Shayna Sarosiek, MD
Marginal Zone Lymphoma
4:10PM - 4:30PM
Ariela Noy, MD
Mantle Cell Lymphoma
4:30PM - 4:50PM
Anita Kumar, MD
Indolent NHL 1: Comprehensive Approaches to Waldenström Macroglobulinemia, Marginal Zone Lymphomas, and Mantle Cell Lymphoma Panel Discussion
4:50PM - 5:05PM
The Evolving Standard of Care
5:05PM - 5:30PM
Kevin David, MD
New drugs in Development
5:30PM - 5:55PM
Meghan C Thompson, MD
Optimizing Chronic Lymphocytic Leukemia Management: Harnessing New Agents for Improved Outcomes Panel Discussion
5:55PM - 6:10PM
 
Breakout Session: Nursing Professional Development

How to Facilitate Rapid Patient Access to MSK: The APP Lymphoma Diagnostic Program
1:35PM - 1:55PM
Jennifer K Lue, MD
Jenna Wenzel, AGNP, AOCNP
Megan Dunne, MA, ANP-C, AOCNP
Adolescent and Young Adult (AYA) Challenges
1:55PM - 2:10PM
Brittany McClain, MSN
Bispecific Therapy in Lymphoma: A Multidisciplinary Practice
2:10PM - 2:30PM
Emily Spevack, BSN
Ashley Ames, FNP-BC, NP
From Research to Patient Care: Optimizing the Role of Clinical Trials Nurses and Advanced Practice Providers
2:30PM - 2:50PM
Helen j Hancock, NP, RN
Anastasia Martinova, BSN
Procedures in Hematologic Malignancy Evaluation and Treatment
2:50PM - 3:10PM
Annalisa Benz, BSN, RN, OCN
Yuliya Ziemann, AGNP
Saturday, April 27, 2024
Recent Advances
8:20AM - 8:45AM
Kate Cwynarski, MD, PhD
New Approaches
8:45AM - 9:00AM
Christian Grommes, MD
ASCT or CAR T cells in CNSL?
9:00AM - 9:15AM
Michael Scordo, MD
Radiation Therapy in CNSL
9:15AM - 9:30AM
Brandon Imber, MD
Persisting Challenges and Open Questions in Primary and Secondary CNS Lymphoma Panel Discussion
9:30AM - 9:45AM
Molecular Pathways in FL
9:45AM - 10:05AM
Hans-Guido Wendel, MD
Recent Insights in FL Classifications
10:05AM - 10:20AM
Pallavi Kanwar Galera, MBBS
Clinical Advances and Persisting Challenges
10:20AM - 10:50AM
Sonali Smith, MD
Strategizing the Sequence of New Therapies in Follicular Lymphoma: A Guide to Optimizing Management Panel Discussion
10:50AM - 11:10AM
Quinlan Sievers, MD, PhD (Presenter)
Deciphering HL Biology
11:30AM - 11:55AM
Christian Steidl, MD, PHD
First Line Therapy
11:55AM - 12:20PM
Ann S LaCasce, MD
Salvage Treatments
12:20PM - 12:40PM
Alison Moskowitz, MD
Hodgkin Lymphoma: Enhancing Treatment Efficacy and Minimizing Side Effects Panel Discussion
12:40PM - 12:55PM

Memorial Sloan Kettering gratefully acknowledges the following organizations for providing medical education grants for this live activity:
AbbVie
AstraZeneca
BeiGene
Bristol-Myers Squibb
Genentech
Janssen Research & Development, LLC
Novartis

Memorial Sloan Kettering is pleased to announce that the following company will be exhibiting during this symposium: 
AbbVie
Bristol-Myers Squibb


CME Courses

Live Courses
On Demand eLearning
Coming Soon

Resources & Policies

CME Program Terms of Use
Registration Discounts
Cancellation Policy
Industry Professionals

Attendee & Faculty Information

My CME / Attendee Resources
Claim RSS Credit (MSK Staff)
Faculty Disclosure Form
Faculty Tasks Page

Connect

Locations & Visitor Info
Help / Contact Us
Subscribe to CME Announcements




MSK CME

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

©2025 Memorial Sloan Kettering Cancer Center